No results matched your search
Genedrive PLC (D6M)

Genedrive PLC (D6M)

Berlin
1.1500 -0.0100 -0.86%
07:08:00 - Closed. Currency in EUR
Create a New Portfolio
CancelCreate
Added to a new portfolio successfully
Add a Comment
Please wait a minute before you try to comment again.
Khine Thin Zar Sint
Khine Thin Zar Sint

Genedrive unveils 15 minutes covid test but why it's going down?   ... (Read More)

Oct 22, 2020 09:32 GMT· 1 · Reply
sinv
sinv

Genedrive® 96 SARS-CoV-2 Kit approved in South Africa  ... (Read More)

Sep 30, 2020 07:48 GMT· 5 · Reply
sinv
sinv

Great news: DIVOC Laboratories received NABL certifications and ICMR permission to offer COVID19 testing in our labs. https://www.divoc.health/news/divoc-laboratories-receive-nabl-and-icmr-certification-for-covid19-testing  ... (Read More)

Sep 18, 2020 10:04 GMT· 1 · Reply
Pro Fessor
Pro Fessor

Liftoff time.    Approvals all due this week.  I was fed up,  waited an absolute eternity and put up with absolute dire SP past few months, now we will all be able to see our wealth increase substantially from here on.    Approvals will see us at 150p in no time.  Easy.  ... (Read More)

Sep 14, 2020 11:29 GMT· Reply
paul barnbrook
paul barnbrook

Pro fessor i think we will finally reap the rewards we have so long waited for next week.You heard it hear first lol  ... (Read More)

Sep 13, 2020 12:35 GMT· 5 · Reply
Ak Shakil
Ak Shakil

Once approvals land this will take off. Partnership with BC very positive  ... (Read More)

Sep 08, 2020 04:16 GMT· 1 · Reply
Pro Fessor
Pro Fessor

See the Lumiradx news today, POC has finally arrived and is the next big thing in this COVID world!  Finally looking great for UK,  not so for PCR companies.  After POC I am guessing breathalysers will be the next big thing!  ... (Read More)

Aug 26, 2020 21:40 GMT· Reply
Pro Fessor
Pro Fessor

Very strange company.    It shouldn't take 2 months to get emergency approval.  That is insane, and there is something the company is not telling us. The announcement on Tuesday was even stranger as Beckmann are already at full capacity and the deal is not exclusive.  Genedrive shouldn't really need to go to automation as the bead format already saves time for workers and does not make sense  when they have moved from swab to saliva sample  extraction method, where they will have to re-engineer a few things again for validation..  V strange.  ... (Read More)

Aug 06, 2020 15:46 GMT· 16 · Reply
Ak Shakil
Ak Shakil

Motoring back up nicely  ... (Read More)

Jul 21, 2020 07:45 GMT· Reply
Rickyc Smiths
Rickyc Smiths

Small gap around 65.27p filled today expect it to be the bottom some news and we are off, could land in the morning or later this week  ... (Read More)

Jul 14, 2020 19:38 GMT· Reply
Muhammed Asif Khan
Muhammed Asif Khan

genedrive have no money left for operational developments.....they are on right track.....but running out of money  ... (Read More)

Jul 14, 2020 11:31 GMT· 4 · Reply
sinv
sinv

what prices point is this a buy again? has fallen below 80p. anyone?  ... (Read More)

Jul 14, 2020 08:49 GMT· Reply
Stephanie Carson
Stephanie Carson

What's going on here - will this go back up anytime soon???   ... (Read More)

Jul 13, 2020 14:28 GMT· Reply
Ak Shakil
Ak Shakil

free falling :(  ... (Read More)

Jul 13, 2020 07:23 GMT· Reply
Muhammed Asif Khan
Muhammed Asif Khan

today rns was good...  ... (Read More)

Jul 10, 2020 13:47 GMT· 1 · Reply
Muhammed Asif Khan
Muhammed Asif Khan

it will go up.....wait  ... (Read More)

Jul 10, 2020 13:47 GMT· Reply
Khine Thin Zar Sint
Khine Thin Zar Sint

What's happening?   ... (Read More)

Jul 10, 2020 12:32 GMT· Reply
sinv
sinv

fasten your seat belts, its about to take off  ... (Read More)

Jul 01, 2020 13:20 GMT· 1 · Reply
Muhammed Asif Khan
Muhammed Asif Khan

if.....delay in announcement might put share a bit down temporarily....  ... (Read More)

Jun 30, 2020 10:41 GMT· Reply
Muhammed Asif Khan
Muhammed Asif Khan

they have to announce SALE end of june......time is up.....they have to not delay now....hope the best with this share....  ... (Read More)

Jun 30, 2020 10:26 GMT· Reply
paul barnbrook
paul barnbrook

this week will have sales news and FDA approval  ,imho the strongest of the new pharm companies and not just a1 trick pony.read there RNS from last year,they have other products ready to release there potential  ... (Read More)

Jun 28, 2020 05:13 GMT· Reply
sinv
sinv

what's happening? quite a drop from 300 to 100  ... (Read More)

Jun 16, 2020 10:40 GMT· 2 · Reply
sinv
sinv

is this a good entry point at 120? or will it go lower?  ... (Read More)

Jun 11, 2020 08:52 GMT· 3 · Reply
Muhammed Asif Khan
Muhammed Asif Khan

no impact on the basis of very good earning report on 3rd june 2020.... ...🤔  ... (Read More)

Jun 04, 2020 07:03 GMT· 2 · Reply
Mike Cook
Mike Cook

genedrive plc (LSE: GDR), the near patient molecular diagnostics company, today announces that an application has been made to the London Stock Exchange for a block listing of 300,000 new ordinary shares of 1.5p each ('Ordinary Shares') in genedrive in respect of Ordinary Shares that are to be allotted under the genedrive 2007 Share Option Scheme.   It is expected that the 300,000 Ordinary Shares will be admitted to trading on 4 June 2020. The shares will rank pari passu with the existing Ordinary Shares of the Company.  ... (Read More)

May 29, 2020 08:38 GMT· Reply
Discussion
Write a reply...
Please wait a minute before you try to comment again.

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

English (USA) English (India) English (Canada) English (Australia) English (South Africa) English (Philippines) English (Nigeria) Deutsch Español (España) Español (México) Français Italiano Nederlands Português (Portugal) Polski Português (Brasil) Русский Türkçe ‏العربية‏ Ελληνικά Svenska Suomi עברית 日本語 한국어 简体中文 繁體中文 Bahasa Indonesia Bahasa Melayu ไทย Tiếng Việt हिंदी
Sign out
Are you sure you want to sign out?
NoYes
CancelYes
Saving Changes

+

Download the Investing.com App

Get free real time quotes, charts and alerts on stocks, indices, currencies, commodities and bonds. Get free top of the line technical analysis/predictors.

Investing.com is better on the App!

More content, faster quotes and charts, and a smoother experience is available only on the App.

';